ZA893651B - 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy - Google Patents

6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy

Info

Publication number
ZA893651B
ZA893651B ZA893651A ZA893651A ZA893651B ZA 893651 B ZA893651 B ZA 893651B ZA 893651 A ZA893651 A ZA 893651A ZA 893651 A ZA893651 A ZA 893651A ZA 893651 B ZA893651 B ZA 893651B
Authority
ZA
South Africa
Prior art keywords
denotes
application
piperazinylalkyl
therapy
phenyl
Prior art date
Application number
ZA893651A
Other languages
English (en)
Inventor
Jonathan Frost
Frost Jonathan
Bernard Gaudilliere
Gaudilliere Bernard
Jean Rousseau
Rousseau Jean
Regis Dupont
Dupont Regis
Philippe Manoury
Manoury Philippe
Daniel Obitz
Obitz Daniel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA893651B publication Critical patent/ZA893651B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
ZA893651A 1988-05-17 1989-05-16 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy ZA893651B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8806568A FR2631625B1 (fr) 1988-05-17 1988-05-17 Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA893651B true ZA893651B (en) 1990-01-31

Family

ID=9366355

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893651A ZA893651B (en) 1988-05-17 1989-05-16 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy

Country Status (20)

Country Link
US (1) US4950670A (enExample)
EP (1) EP0343050B1 (enExample)
JP (1) JPH02138266A (enExample)
KR (1) KR890017244A (enExample)
AT (1) ATE82969T1 (enExample)
AU (1) AU614135B2 (enExample)
CA (1) CA1327577C (enExample)
DE (1) DE68903680T2 (enExample)
DK (1) DK235889A (enExample)
ES (1) ES2045485T3 (enExample)
FI (1) FI892344A7 (enExample)
FR (1) FR2631625B1 (enExample)
GR (1) GR3007118T3 (enExample)
HU (1) HU201057B (enExample)
IE (1) IE891579L (enExample)
IL (1) IL90309A (enExample)
NO (1) NO172437C (enExample)
NZ (1) NZ229144A (enExample)
PT (1) PT90572B (enExample)
ZA (1) ZA893651B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
JP3329534B2 (ja) * 1993-10-20 2002-09-30 株式会社東海理化電機製作所 シフトレバー装置
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
PT957099E (pt) 1998-04-15 2003-02-28 Pfizer Prod Inc Carboxamidas heterociclicas
US6608197B2 (en) * 2000-01-25 2003-08-19 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US7501429B2 (en) * 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
CA2557541C (en) 2004-02-26 2014-12-16 Aska Pharmaceutical Co., Ltd. Pyrimidine derivatives
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
BRPI0511195A (pt) * 2004-05-21 2007-12-04 Pfizer Prod Inc tetraidronaftilpiperazinas como antagonistas da 5-ht1b, agonistas inversos e agonistas parciais
KR102103768B1 (ko) 2018-04-04 2020-04-23 한양대학교 에리카산학협력단 5-ht2c 항진제로서의 활성을 가지는 광학 활성의 2-아미노-4-알콕시 피리미딘 유도체
LT4122926T (lt) 2021-04-14 2025-07-25 Shionogi & Co., Ltd. Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625028A (en) * 1983-07-11 1986-11-25 The Upjohn Company 6-aryluracils and selected novel intermediates used in the preparation thereof
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins

Also Published As

Publication number Publication date
PT90572A (pt) 1989-11-30
US4950670A (en) 1990-08-21
FR2631625B1 (fr) 1992-10-16
NO172437B (no) 1993-04-13
AU3484389A (en) 1989-11-23
DK235889D0 (da) 1989-05-16
IE891579L (en) 1989-11-16
GR3007118T3 (enExample) 1993-07-30
HUT50164A (en) 1989-12-28
JPH02138266A (ja) 1990-05-28
ES2045485T3 (es) 1994-01-16
DE68903680D1 (de) 1993-01-14
CA1327577C (en) 1994-03-08
KR890017244A (ko) 1989-12-15
IL90309A (en) 1994-02-27
NO172437C (no) 1993-07-21
FR2631625A1 (fr) 1989-11-24
EP0343050B1 (fr) 1992-12-02
EP0343050A1 (fr) 1989-11-23
FI892344L (fi) 1989-11-18
DE68903680T2 (de) 1993-06-17
FI892344A0 (fi) 1989-05-16
NO891949D0 (no) 1989-05-16
HU201057B (en) 1990-09-28
DK235889A (da) 1989-11-17
AU614135B2 (en) 1991-08-22
PT90572B (pt) 1994-08-31
ATE82969T1 (de) 1992-12-15
NZ229144A (en) 1990-10-26
FI892344A7 (fi) 1989-11-18
IL90309A0 (en) 1989-12-15
NO891949L (no) 1989-11-20

Similar Documents

Publication Publication Date Title
IL90309A0 (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
ZA924787B (en) 4-pyrimidinecarboxamide derivatives,their preparation and their application in therapy
GR3003481T3 (en) 1-((2-pyrimidinyl)-aminoalkyl) piperidines, their preparation and their use in therapy
GR3007143T3 (enExample)
GR3006371T3 (enExample)
DK0716074T3 (da) Fremgangsmåde til fremstilling af alkylhalogendiflouracetater.
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
HUT65533A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical preparations containing them
AU5170285A (en) Dihydrodithiazine derivatives
HU913212D0 (en) New ergoline derivatives
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.